Bristol-Myers Squibb Co (LTS:0R1F)
$ 59.4 -0.61 (-1.02%) Market Cap: 119.70 Bil Enterprise Value: 163.01 Bil PE Ratio: 0 PB Ratio: 6.98 GF Score: 82/100

Bristol-Myers Squibb Co at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 09:00PM GMT
Release Date Price: $64.65 (-0.19%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Okay. Good afternoon, everyone. I'm Geoff Meacham, I'm the senior biopharma analyst here at BofA. And I have Olivia Brayer from my team with me as well. And welcome to the afternoon session for the Bofa Virtual Vegas Healthcare Conference. We are thrilled to end today with Bristol Myers. And speaking on behalf of Bristol, we have Chris Boerner, who is Executive VP and Chief Commercial Officer. Chris, thanks for joining us.

Christopher S. Boerner
Bristol-Myers Squibb Company - Executive VP & Chief Commercialization Officer

It's my pleasure to be here. Thanks for the invitation.

Questions & Answers

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

And so maybe to kick it off at a higher level, Chris, how should we think about the cadence of growth over the course of this year? Is it a function of trying to see the Opdivo business reaccelerate? Is there an element of all the new launches

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot